Table 3.

Analysis of QLQ-C30 Scores by Treatment Method

Scale	Group	N	Mean	SD	Median	p *
Overall quality of life	BCT	50	62.67	17.11	66.67	0.501
	MTX	50	63	14.3	66.67
	MTX+R	50	65.5	20.2	66.67
Physical functioning	BCT	50	76.8	13.69	80	0.051
	MTX	50	78.67	13.6	80
	MTX+R	50	83.07	12.29	86.67
Functioning in daily activities	BCT	50	79	25.6	83.33	0.32
	MTX	50	81.33	22.24	100
	MTX+R	50	87	17.91	100
Emotional functioning	BCT	50	63.72	22.1	66.67	0.103
	MTX	50	71.17	21.44	75
	MTX+R	50	73	17.05	75
Cognitive functioning	BCT	50	74.67	24.57	75	0.122
	MTX	50	80	24.05	83.33
	MTX+R	50	84.67	17.44	83.33
Social functioning	BCT	50	76.33	22.36	83.33	0.405
	MTX	50	76	17.87	66.67
	MTX+R	50	81	18.14	83.33
Fatigue	BCT	50	43.11	23.4	33.33	0.007
	MTX	50	38	20.71	33.33	BRT>
	MTX+R	50	30	20.36	27.78	MTX+R
Nausea and vomiting	BCT	50	10.33	25.84	0	0.155
	MTX	50	7	13.92	0
	MTX+R	50	3	9.93	0
Pain	BCT	50	26.67	24.97	16.67	0.319
	MTX	50	21	22.54	16.67
	MTX+R	50	20	22.08	16.67
Dyspnoea	BCT	50	14	20.3	0	0.176
	MTX	50	9.33	22.38	0
	MTX+R	50	10	19.34	0
Insomnia	BCT	50	47.33	35.05	33.33	0.063
	MTX	50	36	30.74	33.33
	MTX+R	50	32	33.64	33.33
Appetite loss	BCT	50	18.67	27.9	0	0.032
	MTX	50	16	26.29	0	BRT>
	MTX+R	50	6.67	16.5	0	MTX+R
Constipation	BCT	50	12	21.04	0	0.075
	MTX	50	21.33	24.98	16.67
	MTX+R	50	14	22.43	0
Diarrhoea	BCT	50	8	18.52	0	0.123
	MTX	50	10.67	20.69	0
	MTX+R	50	4.67	16.51	0
Financial difficulties	BCT	50	24	30.15	0	0.013
	MTX	49	35.37	29.19	33.33	MTX>
	MTX+R	50	20	23.33	16.67	Other

Note: *Kruskal–Wallis test + post hoc analysis (Dunn test).